急性胸痛患者的斑块负荷与1年结局:多中心RAPID-CTCA试验结果
该研究为RAPID-CTCA多中心试验的事后分析,对404例疑似急性冠脉综合征患者行定量斑块分析,评估斑块负荷与1年全因死亡或非致死性心肌梗死的关系。结果显示,总斑块、非钙化斑块及低衰减斑块负荷是独立于GRACE评分和阻塞性冠心病的强预测因子,低衰减斑块负荷高于中位数者风险近8倍。
要点
- 低衰减斑块负荷是急性胸痛患者1年死亡或心梗的最强预测因子。
- 总斑块、非钙化斑块负荷亦为独立预测因子,优于阻塞性冠心病。
- 报告时应关注低衰减斑块负荷,而不仅有无阻塞性狭窄。
核心结论
- 在疑似急性冠脉综合征患者中,低衰减斑块负荷是1年死亡或再发心肌梗死的主要预测因子。
- 总斑块、非钙化斑块和低衰减斑块负荷均独立于GRACE评分和阻塞性冠心病预测未来事件。
研究设计与样本
- 研究为多中心RAPID-CTCA试验的事后分析,纳入404例疑似急性冠脉综合征并接受早期冠状动脉CT血管造影的患者。
- 采用定量斑块分析,评估1年全因死亡或非致死性心肌梗死与GRACE评分、阻塞性冠心病及斑块负荷的关联。
关键影像表现/征象
- 发生主要终点事件的患者总斑块负荷更高(46% [IQR: 43%-50%] vs 36% [IQR: 21%-46%];P < 0.001)。
- 非钙化斑块负荷更高(41% [IQR: 37%-47%] vs 33% [IQR: 20%-41%];P < 0.001)。
- 低衰减斑块负荷更高(4.22% [IQR: 3.3%-5.68%] vs 2.14% [IQR: 0.5%-4.88%];P < 0.001)。
- 阻塞性冠心病与主要终点无显著关联(P = 0.065)。
诊断标准与关键数值
- 低衰减斑块负荷高于中位数者主要终点风险显著增加(HR: 7.80 [95% CI: 2.33-26.0];P < 0.001)。
- GRACE评分>140的HR为3.80(95% CI: 1.45-6.98;P = 0.004)。
- 阻塞性冠心病的HR为2.07(95% CI: 0.94-4.53;P = 0.07)。
- 总斑块、非钙化斑块和低衰减斑块负荷独立预测未来事件(P ≤ 0.002 for all)。
临床应用与阅片要点
- 在急性胸痛冠脉CTA报告中,除狭窄程度外应定量评估低衰减斑块负荷。
- 低衰减斑块负荷高于中位数提示1年事件风险近8倍,可辅助风险分层。
- 阻塞性冠心病并非唯一预测指标,需综合斑块负荷评估。
局限性
- 本研究为事后分析,可能存在选择偏倚和未测量混杂。
- 原文未报告多中心具体中心数及设备/序列细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with stable chest pain, computed tomography (CT) plaque burden is an independent predictor of future coronary events.
OBJECTIVES: The purpose of this study was to determine whether plaque burden and characteristics can predict subsequent death or myocardial infarction in patients with acute chest pain.
METHODS: In a post hoc analysis of a multicenter trial of early coronary CT angiography, the authors performed quantitative plaque analysis to assess the association between primary endpoint of 1-year all-cause death or nonfatal myocardial infarction and the GRACE (Global Registry of Acute Coronary Events) score, presence of obstructive coronary artery disease, and plaque burden in 404 patients with suspected acute coronary syndrome.
RESULTS: Following the index event, 25 patients had a primary event that was associated with a higher GRACE score (134 ± 44 vs 113 ± 35; P = 0.012), larger burdens of total (46% [IQR: 43%-50%] vs 36% [IQR: 21%-46%]; P < 0.001), noncalcified (41% [IQR: 37%-%47] vs 33% [IQR: 20%-41%]; P < 0.001), and low-attenuation plaque (4.22% [IQR: 3.3%-5.68%] vs 2.14% [IQR: 0.5%-4.88%]; P < 0.001), but not obstructive coronary artery disease (P = 0.065). Total, noncalcified, and low-attenuation plaque burden were the strongest predictors of future events independent of GRACE score and obstructive coronary artery disease (P ≤ 0.002 for all). Patients with a low-attenuation burden above the median had nearly an 8-fold increased risk of the primary endpoint (HR: 7.80 [95% CI: 2.33-26.0]; P < 0.001), outperforming either a GRACE score of >140 (HR: 3.80 [95% CI :1.45-6.98]; P = 0.004) or obstructive coronary artery disease (HR: 2.07 [95% CI: 0.94-4.53]; P = 0.07).
CONCLUSIONS: In patients with suspected acute coronary syndrome, low-attenuation plaque burden is a major predictor of 1-year death or recurrent myocardial infarction. (Rapid Assessment of Potential Ischaemic Heart Disease With CTCA [RAPID-CTCA]; NCT02284191).
引用
- Meah, Tzolos, Wang, et al. Plaque Burden and 1-Year Outcomes in Acute Chest Pain: Results From the Multicenter RAPID-CTCA Trial. JACC Cardiovasc Imaging. 2022. PMID: 36357133. doi:10.1016/j.jcmg.2022.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。